Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
Oncotarget
.
2018 Jul 6;9(52):30024.
doi: 10.18632/oncotarget.25776.
Authors
Saurabh Agarwal
1
,
Giorgio Milazzo
2
,
Kimal Rajapakshe
3
,
Ronald Bernardi
1
,
Zaowen Chen
1
,
Barbieri Eveline
1
,
Jan Koster
4
,
Giovanni Perini
2
,
Cristian Coarfa
3
,
Jason M Shohet
1
Affiliations
1
Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
2
Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
3
Dan L Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
4
Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
PMID:
30042831
PMCID:
PMC6057463
DOI:
10.18632/oncotarget.25776
Abstract
[This corrects the article DOI: 10.18632/oncotarget.24859.].
Publication types
Published Erratum
Grants and funding
R01 CA174808/CA/NCI NIH HHS/United States